Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: AMG 479|DRUG: Trastuzumab
Sponsor: M.D. Anderson Cancer Center
Collaborators: Amgen